PEPG

PEPGEN INC

PEPG·713317105·US·Common Stock·Healthcare - Biotechnology-Activist

PEPG (PEPGEN INC) is held by 55 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($35.5M), VIKING GLOBAL INVESTORS LP ($6.2M), MILLENNIUM MANAGEMENT LLC ($3.7M). Net institutional sentiment: Mixed.

55
Holders
Avg rating(5 Elite)
$66.8M
Total Value
51% (62)
Fund Consensus
28 buying - 27 selling
PEPGSmart Money Verdict
View all
Held by 55 funds
5 elite
Who's Trading
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP5.0%May 15, 2026
ActivistCOCommodore Capital LP6.5%May 15, 2026
InsiderMGMcArthur James GSell $32KMar 4, 2026
InsiderMGMcArthur James GSell $828.575Mar 4, 2026
InsiderDNDonnelly NoelSell $13KMar 4, 2026
InsiderDNDonnelly NoelSell $328.9Mar 4, 2026
InsiderSPSTRECK PAULSell $11KMar 4, 2026
InsiderSPSTRECK PAULSell $295.536Mar 4, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.3.0%Nov 14, 2025
ActivistOSOxford Science Enterprises plc7.2%Oct 1, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
20.1M$35.5M0.4%-71.66%
0
Unchanged
3.5M$6.2M0.0%-67.01%
0
Increased
2.1M(+950.4%)$3.7M0.0%-60.79%
43
New
1.9M$3.4M0.0%-63.55%
37
Unchanged
1.3M$2.3M0.0%-21.30%
0
Decreased
1.3M(-3.4%)$2.3M0.0%-59.56%
0
Increased
1.3M(+3.5%)$2.3M0.0%-57.47%
18
Decreased
998,987(-7.9%)$1.8M0.0%-57.30%
0
Increased
706,472(+2161.9%)$1.3M0.0%-63.55%
41
Decreased
535,999(-1.1%)$949,2280.0%-73.09%
0
Increased
442,168(+252.3%)$782,6370.0%-58.41%
40
Increased
298,568(+2.8%)$528,4660.0%-63.55%
25
Decreased
279,909(-11.1%)$495,4390.0%-49.57%
0
New
259,697$459,6640.0%-63.55%
33
Increased
229,390(+5.5%)$406,0200.0%-67.93%
17
Increased
216,824(+60.4%)$394,1010.0%-64.69%
34
Decreased
207,922(-22.4%)$368,0220.0%-49.57%
0
Increased
197,391(+2.4%)$349,3820.0%-63.55%
16
Decreased
181,705(-32.0%)$321,6180.0%-53.47%
0
New
158,826$281,1220.0%-63.55%
32

Showing 1-20 of 62

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used